Loading
Radiation oncologist who developed adaptive liver radiotherapy and radiosensitising drug combinations.
Theodore S. Lawrence is the Isadore Lampe Professor of Radiation Oncology at the University of Michigan Rogel Cancer Center. He is a radiation oncologist known for developing individualised adaptive radiotherapy for liver tumours and radiosensitising drug combinations that target the DNA damage response. His selected paper reports individualised adaptive stereotactic body radiotherapy for liver cancer. A former chair of radiation oncology at Michigan, he continues to work on stereotactic and image-guided radiotherapy in hepatocellular and pancreatic cancer.
| Title | Journal | Year |
|---|---|---|
| Individualized adaptive stereotactic body radiotherapy for liver cancer | Journal of Clinical Oncology | 2016 |
Shares University of Michigan Rogel Cancer Center, Pancreatic ductal adenocarcinoma.
Shares Locally advanced unresectable pancreatic ductal adenocarcinoma, SBRT / SABR (stereotactic radiotherapy), Hepatocellular carcinoma, Pancreatic ductal adenocarcinoma.
Shares Locally advanced unresectable pancreatic ductal adenocarcinoma, SBRT / SABR (stereotactic radiotherapy), IMRT / IGRT (modern external beam), Pancreatic ductal adenocarcinoma.
Shares SBRT / SABR (stereotactic radiotherapy), Hepatocellular carcinoma, IMRT / IGRT (modern external beam), Pancreatic ductal adenocarcinoma.
Shares Locally advanced unresectable pancreatic ductal adenocarcinoma, IMRT / IGRT (modern external beam), Pancreatic ductal adenocarcinoma.
Shares American Society for Radiation Oncology, SBRT / SABR (stereotactic radiotherapy), IMRT / IGRT (modern external beam).
Shares Locally advanced unresectable pancreatic ductal adenocarcinoma, SBRT / SABR (stereotactic radiotherapy).
Shares Locally advanced unresectable pancreatic ductal adenocarcinoma, SBRT / SABR (stereotactic radiotherapy).